The US is the leading destination market for greenfield pharmaceuticals FDI, while it is also the top source market. GlobalData’s pharmaceuticals foreign direct investment (FDI) report highlights the current trends in pharmaceuticals foreign investments. Buy the report here.

Between 2019 and 2022, the pharmaceuticals sector was the fifteenth largest FDI sector in terms of the number of greenfield investments. The pharmaceuticals sector accounts for 2% of global greenfield FDI projects.

Greenfield foreign direct investment is when a company invests abroad to establish a new physical presence or expand an existing operation. Greenfield investments create jobs and/or involve a capital investment into the foreign location. Other forms of FDI, such as mergers and acquisitions, are not included as part of this definition.

Combined, the top ten destination countries account for 58.3% of total pharmaceuticals FDI projects.

The leading destination country for pharmaceuticals FDI is the US. Germany, UK and France are also popular pharmaceuticals investment hubs.

According to GlobalData’s FDI Projects database, United Kingdom-based companies were the leading source of greenfield pharmaceuticals investments into the US.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

With respect to outbound FDI, the US was the leading pharmaceuticals source market. US-based companies held a 26.3% share of total outbound pharmaceuticals FDI projects. Germany, UK, Switzerland and Japan are also top source markets for pharmaceuticals FDI.

To further understand global pharmaceuticals foreign direct investment trends, buy the report here.